摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2'-Chloro-6'-methylpyrido-4'-yl)piperazine | 179334-19-1

中文名称
——
中文别名
——
英文名称
1-(2'-Chloro-6'-methylpyrido-4'-yl)piperazine
英文别名
1-(2-Chloro-6-methyl-4-pyridinyl)piperazine;1-(2-chloro-6-methylpyridin-4-yl)piperazine
1-(2'-Chloro-6'-methylpyrido-4'-yl)piperazine化学式
CAS
179334-19-1
化学式
C10H14ClN3
mdl
——
分子量
211.694
InChiKey
YGJOVMGKFJINKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    28.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    Certain substituted 1-aryl-3-piperazin-1′-yl propanones
    摘要:
    公开的是以下式I的化合物: 其中X是羰基、磺酰基、亚甲基或与可选择取代的苯基取代的亚甲基; Z是氮或CH; Ar1和Ar2分别代表芳基; Y是氢;或Y和R1或R2一起代表CH2;CH2CH2;CH2O;CH2S,形成五元或六元环,该环可选择地取代为较低的烷基或苯基;或其药用可接受的盐,用于治疗肿瘤性疾病,细菌或真菌感染,并防止或减少与阿尔茨海默病相关的异常磷酸化成对螺旋丝表位(PHF)的产生,因此,可用于治疗阿尔茨海默病。
    公开号:
    US06214994B1
点击查看最新优质反应信息

文献信息

  • Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat
    申请人:Molecular Geriatrics Corporation
    公开号:US05658909A1
    公开(公告)日:1997-08-19
    Disclosed are compounds of formula I: ##STR1## or the pharmaceutically acceptable salts thereof wherein X is a carbonyl, sulfonyl, methylene, or methylene substituted with optionally substituted phenyl; Z is nitrogen or CH; Ar.sub.1 and Ar.sub.2 independently represent aryl groups; and Y is hydrogen; or Y and R.sub.1 or R.sub.2 together represent CH.sub.2 ; CH.sub.2 CH.sub.2 ; CH.sub.2 O; CH.sub.2 S forming a five or six membered ring and such ring may be optionally substituted with loweralkyl or phenyl; or pharmaceutically acceptable salts thereof, useful in the treatment of neoplastic diseases, and bacterial or fungal infections, and for preventing or decreasing the production of abnormally phosphorylated paired helical filament (PHF) epitopes associated with Alzheimer's Disease and, therefore for treating Alzheimer's Disease.
    揭示了以下式I的化合物:##STR1##或其药学上可接受的盐,其中X是羰基、磺酰基、亚甲基或亚甲基,或者亚甲基上带有可选择取代的苯基;Z是氮或CH;Ar.sub.1和Ar.sub.2分别代表芳基;Y是氢;或者Y和R.sub.1或R.sub.2一起代表CH.sub.2;CH.sub.2 CH.sub.2;CH.sub.2 O;CH.sub.2 S形成五元或六元环,该环可以选择性地取代为较低的烷基或苯基;或其药学上可接受的盐,用于治疗肿瘤性疾病,细菌或真菌感染,并用于预防或减少与阿尔茨海默病相关的异常磷酸化成对螺旋丝(PHF)表位的产生,因此用于治疗阿尔茨海默病。
  • Substituted 1-aryl-3-piperazin-1'-yl propanones
    申请人:Molecular Geriatrics Corporation
    公开号:US05693804A1
    公开(公告)日:1997-12-02
    Disclosed are compounds of formula I: ##STR1## wherein X is a carbonyl, sulfonyl, methylene, or methylene substituted with optionally substituted phenyl; Z is nitrogen or CH; Ar.sub.1 and Ar.sub.2 independently represent aryl groups; and Y is hydrogen; or Y and R.sub.1 or R.sub.2 together represent CH.sub.2 ;CH.sub.2 CH.sub.2 ; CH.sub.2 O; CH.sub.2 S forming a five or six membered ring and such ring may be optionally substituted with loweralkyl or phenyl; or the pharmaceutically acceptable salts thereof, useful in the treatment of neoplastic diseases, and bacterial or fungal infections, and in preventing or decreasing the production of abnormally phosphorylated paired helical filament (PHF) epitopes associated with Alzheimer's Disease and, therefore, useful for treating Alzheimer's Disease.
    揭示了以下式I的化合物:##STR1## 其中X是羰基、磺酰基、亚甲基或亚甲基,或者亚甲基上带有可选择取代的苯基;Z是氮或CH;Ar.sub.1和Ar.sub.2分别代表芳基;Y是氢;或者Y和R.sub.1或R.sub.2一起代表CH.sub.2;CH.sub.2 CH.sub.2;CH.sub.2 O;CH.sub.2 S形成五元或六元环,该环可以选择性地用较低烷基或苯基取代;或其药学上可接受的盐,用于治疗肿瘤性疾病,细菌或真菌感染,并预防或减少与阿尔茨海默病相关的异常磷酸化成对螺旋丝(PHF)表位的产生,因此,用于治疗阿尔茨海默病。
  • Certain substituted 1-aryl-3-piperazine-1'-yl propanones
    申请人:Molecular Geriatarics Corporation
    公开号:US20010025105A1
    公开(公告)日:2001-09-27
    Disclosed are compounds of formula I: 1 wherein X is a carbonyl, sulfonyl, methylene, or methylene substituted with optionally substituted phenyl; Z is nitrogen or CH; Ar 1 and Ar 2 independently represent aryl groups; and Y is hydrogen; or Y and R 1 or R 2 together represent CH 2 ;CH 2 CH 2 ; CH 2 O; CH 2 S forming a five or six membered ring and such ring may be optionally substituted with loweralkyl or phenyl; or the pharmaceutically acceptable salts thereof, useful in the treatment of neoplastic diseases, and bacterial or fungal infections, and in preventing or decreasing the production of abnormally phosphorylated paired helical filament (PHF) epitopes associated with Alzheimer's Disease and, therefore, useful for treating Alzheimer's Disease.
    公开了式 I 的化合物: 1 其中 X 是羰基、磺酰基、亚甲基或被任选取代的苯基取代的亚甲基; Z 是氮或 CH; Ar 1 和 Ar 2 分别代表芳基;和 Y 是氢;或 Y 和 R 1 或 R 2 共同代表 CH 2 ;CH 2 CH 2 ;CH 2 O; CH 2 或其药学上可接受的盐,可用于治疗肿瘤性疾病、细菌或真菌感染,以及预防或减少与阿尔茨海默氏症相关的异常磷酸化成对螺旋丝(PHF)表位的产生,因此可用于治疗阿尔茨海默氏症。
  • CERTAIN SUBSTITUTED 1-ARYL-3-PIPERAZIN-1'-YL PROPANONES
    申请人:MOLECULAR GERIATRICS CORPORATION
    公开号:EP0792269A2
    公开(公告)日:1997-09-03
  • US5658909A
    申请人:——
    公开号:US5658909A
    公开(公告)日:1997-08-19
查看更多